Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain

Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of ox...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 1998-07, Vol.799 (1), p.78-83
Hauptverfasser: Kokoshka, Jerry M, Metzger, Ryan R, Wilkins, Diana G, Gibb, James W, Hanson, Glen R, Fleckenstein, Annette E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 83
container_issue 1
container_start_page 78
container_title Brain research
container_volume 799
creator Kokoshka, Jerry M
Metzger, Ryan R
Wilkins, Diana G
Gibb, James W
Hanson, Glen R
Fleckenstein, Annette E
description Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [ 3 H ]serotonin ([ 3 H ]5HT) and [ 3 H ]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [ 3 H ]5HT transport; an effect attributable to a decrease in V max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [ 3 H ]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment.
doi_str_mv 10.1016/S0006-8993(98)00472-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80011552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006899398004727</els_id><sourcerecordid>16485342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</originalsourceid><addsrcrecordid>eNqFkU1P3DAQhi3UCrbQn4CUA6qoRNrxVz5OVYVaQKLqofRs2c6ENUqcYDtI--_xsqu9crKteR6P_Q4h5xS-UaDV938AUJVN2_LLtvkKIGpW1kdkRZu8qZiAD2R1QE7Ipxif8pHzFo7JcVtVFTRiRcwfTGs9zmtMenQeixRQpxF9KoKeXTdsCufXzrgUi4hhSpN3_qowSyr8lIrHYcmeTniVRe3jPIWEIWYn66kwQTt_Rj72eoj4eb-ekv-_fz1c35b3f2_urn_el1YwSKXh3MraGCMNGkY1ag6coYae17YzHGuULe8Zr-uON71ECcJICSipZFZU_JR82d07h-l5wZjU6KLFYdAepyWqBoBSKdm7IK1EI7nYgnIH2jDFGLBXc3CjDhtFQW2HoN6GoLYJq7ZRb0NQdfbO9w0WM2J3sPap5_rFvq6j1UOfk7MuHjDGBWVy-6EfOwxzai8Og4rWobfYuYA2qW5y7zzkFSFApN8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16485342</pqid></control><display><type>article</type><title>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kokoshka, Jerry M ; Metzger, Ryan R ; Wilkins, Diana G ; Gibb, James W ; Hanson, Glen R ; Fleckenstein, Annette E</creator><creatorcontrib>Kokoshka, Jerry M ; Metzger, Ryan R ; Wilkins, Diana G ; Gibb, James W ; Hanson, Glen R ; Fleckenstein, Annette E</creatorcontrib><description>Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [ 3 H ]serotonin ([ 3 H ]5HT) and [ 3 H ]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [ 3 H ]5HT transport; an effect attributable to a decrease in V max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [ 3 H ]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment.</description><identifier>ISSN: 0006-8993</identifier><identifier>EISSN: 1872-6240</identifier><identifier>DOI: 10.1016/S0006-8993(98)00472-7</identifier><identifier>PMID: 9666084</identifier><identifier>CODEN: BRREAP</identifier><language>eng</language><publisher>London: Elsevier B.V</publisher><subject>Amino Acid Transport System X-AG ; Animals ; ATP-Binding Cassette Transporters - metabolism ; Biological and medical sciences ; Carrier Proteins - antagonists &amp; inhibitors ; Corpus Striatum - drug effects ; Corpus Striatum - metabolism ; Glutamate ; Glutamic Acid - pharmacokinetics ; Male ; Medical sciences ; Membrane Glycoproteins - antagonists &amp; inhibitors ; Membrane Transport Proteins ; Methamphetamine ; Methamphetamine - pharmacology ; Nerve Tissue Proteins ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Sprague-Dawley ; Serotonin ; Serotonin - pharmacokinetics ; Serotonin Plasma Membrane Transport Proteins ; Striatum ; Synaptosomes - drug effects ; Synaptosomes - metabolism ; Time Factors ; Transporter ; Xanthine Oxidase - pharmacology</subject><ispartof>Brain research, 1998-07, Vol.799 (1), p.78-83</ispartof><rights>1998 Elsevier Science B.V.</rights><rights>1998 INIST-CNRS</rights><rights>Copyright 1998 Elsevier Science B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</citedby><cites>FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0006899398004727$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2341256$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9666084$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kokoshka, Jerry M</creatorcontrib><creatorcontrib>Metzger, Ryan R</creatorcontrib><creatorcontrib>Wilkins, Diana G</creatorcontrib><creatorcontrib>Gibb, James W</creatorcontrib><creatorcontrib>Hanson, Glen R</creatorcontrib><creatorcontrib>Fleckenstein, Annette E</creatorcontrib><title>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</title><title>Brain research</title><addtitle>Brain Res</addtitle><description>Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [ 3 H ]serotonin ([ 3 H ]5HT) and [ 3 H ]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [ 3 H ]5HT transport; an effect attributable to a decrease in V max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [ 3 H ]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment.</description><subject>Amino Acid Transport System X-AG</subject><subject>Animals</subject><subject>ATP-Binding Cassette Transporters - metabolism</subject><subject>Biological and medical sciences</subject><subject>Carrier Proteins - antagonists &amp; inhibitors</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - metabolism</subject><subject>Glutamate</subject><subject>Glutamic Acid - pharmacokinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - antagonists &amp; inhibitors</subject><subject>Membrane Transport Proteins</subject><subject>Methamphetamine</subject><subject>Methamphetamine - pharmacology</subject><subject>Nerve Tissue Proteins</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Serotonin</subject><subject>Serotonin - pharmacokinetics</subject><subject>Serotonin Plasma Membrane Transport Proteins</subject><subject>Striatum</subject><subject>Synaptosomes - drug effects</subject><subject>Synaptosomes - metabolism</subject><subject>Time Factors</subject><subject>Transporter</subject><subject>Xanthine Oxidase - pharmacology</subject><issn>0006-8993</issn><issn>1872-6240</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1P3DAQhi3UCrbQn4CUA6qoRNrxVz5OVYVaQKLqofRs2c6ENUqcYDtI--_xsqu9crKteR6P_Q4h5xS-UaDV938AUJVN2_LLtvkKIGpW1kdkRZu8qZiAD2R1QE7Ipxif8pHzFo7JcVtVFTRiRcwfTGs9zmtMenQeixRQpxF9KoKeXTdsCufXzrgUi4hhSpN3_qowSyr8lIrHYcmeTniVRe3jPIWEIWYn66kwQTt_Rj72eoj4eb-ekv-_fz1c35b3f2_urn_el1YwSKXh3MraGCMNGkY1ag6coYae17YzHGuULe8Zr-uON71ECcJICSipZFZU_JR82d07h-l5wZjU6KLFYdAepyWqBoBSKdm7IK1EI7nYgnIH2jDFGLBXc3CjDhtFQW2HoN6GoLYJq7ZRb0NQdfbO9w0WM2J3sPap5_rFvq6j1UOfk7MuHjDGBWVy-6EfOwxzai8Og4rWobfYuYA2qW5y7zzkFSFApN8</recordid><startdate>19980713</startdate><enddate>19980713</enddate><creator>Kokoshka, Jerry M</creator><creator>Metzger, Ryan R</creator><creator>Wilkins, Diana G</creator><creator>Gibb, James W</creator><creator>Hanson, Glen R</creator><creator>Fleckenstein, Annette E</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19980713</creationdate><title>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</title><author>Kokoshka, Jerry M ; Metzger, Ryan R ; Wilkins, Diana G ; Gibb, James W ; Hanson, Glen R ; Fleckenstein, Annette E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-b33c57bbb5beb21aea3032ea0f37cdb3e7e593f2377d38f5e504b550e5152c463</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Amino Acid Transport System X-AG</topic><topic>Animals</topic><topic>ATP-Binding Cassette Transporters - metabolism</topic><topic>Biological and medical sciences</topic><topic>Carrier Proteins - antagonists &amp; inhibitors</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - metabolism</topic><topic>Glutamate</topic><topic>Glutamic Acid - pharmacokinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - antagonists &amp; inhibitors</topic><topic>Membrane Transport Proteins</topic><topic>Methamphetamine</topic><topic>Methamphetamine - pharmacology</topic><topic>Nerve Tissue Proteins</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Serotonin</topic><topic>Serotonin - pharmacokinetics</topic><topic>Serotonin Plasma Membrane Transport Proteins</topic><topic>Striatum</topic><topic>Synaptosomes - drug effects</topic><topic>Synaptosomes - metabolism</topic><topic>Time Factors</topic><topic>Transporter</topic><topic>Xanthine Oxidase - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kokoshka, Jerry M</creatorcontrib><creatorcontrib>Metzger, Ryan R</creatorcontrib><creatorcontrib>Wilkins, Diana G</creatorcontrib><creatorcontrib>Gibb, James W</creatorcontrib><creatorcontrib>Hanson, Glen R</creatorcontrib><creatorcontrib>Fleckenstein, Annette E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kokoshka, Jerry M</au><au>Metzger, Ryan R</au><au>Wilkins, Diana G</au><au>Gibb, James W</au><au>Hanson, Glen R</au><au>Fleckenstein, Annette E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain</atitle><jtitle>Brain research</jtitle><addtitle>Brain Res</addtitle><date>1998-07-13</date><risdate>1998</risdate><volume>799</volume><issue>1</issue><spage>78</spage><epage>83</epage><pages>78-83</pages><issn>0006-8993</issn><eissn>1872-6240</eissn><coden>BRREAP</coden><abstract>Previous studies have demonstrated that multiple methamphetamine (METH) administrations rapidly and reversibly decrease dopamine transporter activity assessed in striatal synaptosomes. A role for reactive oxygen species was suggested by findings that: (1) METH treatment increases the formation of oxygen radicals in vivo; and (2) oxygen radicals, generated by the enzyme xanthine oxidase, attenuate dopamine uptake in vitro. To test the selectivity of transporter responses, the present study examined effects of METH and xanthine oxidase on [ 3 H ]serotonin ([ 3 H ]5HT) and [ 3 H ]glutamate transport into striatal synaptosomes. Multiple doses of METH, or incubation with xanthine oxidase, rapidly attenuated [ 3 H ]5HT transport; an effect attributable to a decrease in V max. The METH-induced decrease in transport activity completely recovered by 24 h, but was decreased again 1 week later. In contrast, [ 3 H ]glutamate transport was essentially unchanged after METH treatment or incubation with xanthine oxidase. These findings indicate that: (1) METH causes a rapid and reversible decrease in 5HT transporter activity; and (2) glutamate transporters are less susceptible than 5HT transporters to effects of reactive species or METH treatment.</abstract><cop>London</cop><cop>Amsterdam</cop><cop>New York, NY</cop><pub>Elsevier B.V</pub><pmid>9666084</pmid><doi>10.1016/S0006-8993(98)00472-7</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-8993
ispartof Brain research, 1998-07, Vol.799 (1), p.78-83
issn 0006-8993
1872-6240
language eng
recordid cdi_proquest_miscellaneous_80011552
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Amino Acid Transport System X-AG
Animals
ATP-Binding Cassette Transporters - metabolism
Biological and medical sciences
Carrier Proteins - antagonists & inhibitors
Corpus Striatum - drug effects
Corpus Striatum - metabolism
Glutamate
Glutamic Acid - pharmacokinetics
Male
Medical sciences
Membrane Glycoproteins - antagonists & inhibitors
Membrane Transport Proteins
Methamphetamine
Methamphetamine - pharmacology
Nerve Tissue Proteins
Neuropharmacology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Rats
Rats, Sprague-Dawley
Serotonin
Serotonin - pharmacokinetics
Serotonin Plasma Membrane Transport Proteins
Striatum
Synaptosomes - drug effects
Synaptosomes - metabolism
Time Factors
Transporter
Xanthine Oxidase - pharmacology
title Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A41%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methamphetamine%20treatment%20rapidly%20inhibits%20serotonin,%20but%20not%20glutamate,%20transporters%20in%20rat%20brain&rft.jtitle=Brain%20research&rft.au=Kokoshka,%20Jerry%20M&rft.date=1998-07-13&rft.volume=799&rft.issue=1&rft.spage=78&rft.epage=83&rft.pages=78-83&rft.issn=0006-8993&rft.eissn=1872-6240&rft.coden=BRREAP&rft_id=info:doi/10.1016/S0006-8993(98)00472-7&rft_dat=%3Cproquest_cross%3E16485342%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16485342&rft_id=info:pmid/9666084&rft_els_id=S0006899398004727&rfr_iscdi=true